Overview
The women's health and wellness industry is expanding rapidly, presenting exciting opportunities.
Our team provides strategic guidance to clients navigating the unique challenges and complexities of this evolving and often misunderstood field.
Globally, the women’s health market was estimated at $49.33 billion in 2024 and is projected to increase at a compound annual growth rate of 5.1 percent between 2025 and 2030, fueled in part by an aging population and the development of new therapeutic products tailored to women’s health.
Historically, the women’s health and wellness industry has faced challenges in attracting investment due to underrecognized market potential, a limited pool of innovators, minimal prior investments in the sector, and a shifting political and regulatory landscape.
Today, there is widespread acknowledgment of the white space and untapped market opportunity in women’s health. This has created significant momentum around innovation, including, but not limited to, FemTech, to improve health care experiences, access, and outcomes for women at every stage of their life cycle.
As one of the nation’s premier law firms practicing in both health care and employment law, Epstein Becker Green is exceptionally well positioned to guide clients navigating women’s health care innovation, delivery, and benefit coverage. Our attorneys, along with consultants from our affiliate, EBG Advisors, Inc. (EBGA), and strategic advisors and advocates from National Health Advisors (NHA), provide strategic legal, business, and advocacy advice to investors, health care providers, FemTech companies, employers, and other women’s health organizations.
How We Support Growth and Innovation
Given the interdisciplinary nature of women’s health and wellness—covering areas ranging from hormonal, mental, reproductive, and heart health to fertility, maternal care, menopause, and cancers affecting women to aesthetic medspa services, vitamins and supplements, and more—our Epstein Becker Green team brings together knowledge and experience across a variety of practices to address the challenges faced by businesses and investors in this space. We offer comprehensive guidance in:
- Artificial intelligence
- Clinical research
- Corporate practice of medicine
- Digital health
- Employee benefits
- Health policy and legislation
- Incorporation and creation and maintenance of LLCs and corporations
- Intellectual property (IP) protection
- Licensure and scope of practice
- Medical devices, pharmaceuticals, and FDA authorizations
- Mental health parity
- Mergers, acquisitions & divestitures
- Privacy laws, including safeguarding sensitive women's health data
- Reimbursement
- Telehealth and virtual care solutions
- Technology, including health care software
Our women’s health and wellness clients choose us to provide critical guidance as they navigate this dynamic space based on our deep understanding of the ever-evolving legal, regulatory, and policy landscape, including the challenges created by the U.S. Supreme Court’s Dobbs decision. We work closely with providers and innovators across the business life cycle—from research and development to payment, coverage, and compliance. We also work alongside business teams of all sizes that leverage innovation and technology to improve women’s health. For venture capital and private equity funds, we offer critical insights into evaluating health-related investment targets.
In addition, our attorneys are supported by a robust network of consultants and technical advisors from EBGA, who can assist with various matters, including, but not limited to, research and development; coding, coverage, and payment; public policy; business strategy; crisis communications; and data security. When advocacy on Capitol Hill is required, the skilled advocates at NHA can provide lobbying assistance as well.
Whether you’re an investor, health care provider, FemTech innovator, or other organization committed to women’s health and wellness, our multidisciplinary team can provide the guidance you need to navigate this complex and high-potential sector.
Experience
- Provided guidance on the expansion of telehealth services to address the increasing demand for postpartum mental health services.
- Represented an international private equity client in connection with the client’s acquisition of one of the largest medical groups of women’s health care clinicians in the United States.
- Advised one of the largest management services organizations in the United States dedicated to supporting women’s health care clinicians.
- Provided strategic and legal/landscape advice for an international private equity client that was considering an investment in the fertility space in the U.S. market.
Contacts
- Member of the Firm
- Member of the Firm
- Strategic Counsel
Insights
Insights
- PublicationsTakeaways from State Votes on Abortion in the 2024 Election2 minute read
- BlogsInvestors, Researchers, and Business Leaders Take Note: $110M Awarded to Advance Women’s Health4 minute read
- BlogsGeorgia & North Dakota: More State Judges Question the Constitutionality of Abortion Bans11 minute read
- BlogsVideo: New HIPAA Final Rule - Key Changes to Reproductive Health Care Privacy – Thought Leaders in Health Law3 minute read
- BlogsTexas Supreme Court Declines Opportunity to Hear Personhood Case7 minute read
- BlogsSupreme Court Rejects Challenge to FDA Approval of Mifepristone on Standing, but the Battle Continues9 minute read
- BlogsFDA Wins Mifepristone Case, NLRB Denied Lower Injunctive Relief Standards, and “Trump Too Small” Denied Trademark ...7 minute read
- BlogsInterested in Opening a Medical Spa? (Part II): Here’s (More) That You Need to Know7 minute read
- BlogsLouisiana Becomes First State to Classify Mifepristone and Misoprostol as Controlled Substances13 minute read
- BlogsHHS Publishes Final Rule to Support Reproductive Health Care Privacy10 minute read
- PublicationsState Supreme Courts and Ballot Initiatives: Arizona, Florida Exemplify the Abortion Battle Playing Out in the States ...14 minute read
- BlogsInterested in Opening a Medical Spa? Here’s What You Need to Know7 minute read
- BlogsUpdate: Alabama Legislature Moves to Shield IVF from “Personhood” Ruling5 minute read
- BlogsIn Alabama, Pre-Embryos are “Extrauterine Children” Under the State’s Wrongful Death Statute11 minute read
- BlogsCMS Announces Comprehensive Plan to Ensure EMTALA Compliance8 minute read
Focus Areas
Services
- Academic and Clinical Research
- Behavioral Health
- Corporate & Transactional
- Corporate Practice of Medicine
- Data Protection
- Digital Health
- Drug and Medical Device Coding, Coverage, and Payment
- Employee Benefits and ERISA
- General Counsel Services
- Government and Commercial Coding, Coverage, and Payment
- Health Care
- Health Care and Life Sciences Investor Services
- Health Care Mergers and Acquisitions
- Health Policy and Legislation
- Intellectual Property
- Life Sciences
- Managed Care
- Mental Health Parity
- Mergers, Acquisitions & Divestitures
- Privacy, Cybersecurity & Data Asset Management
- Regulatory Strategy, Product Development, and Product Approvals
- Telehealth
Industries
- Academic Medical Centers
- Ambulatory Care Facilities
- Cannabis
- Health Care Industry
- Health Plans and Other Insurers
- Home Health, Hospice & Community-Based Providers
- Hospitals and Health Systems
- Life Sciences Industry
- Pharmacies
- Physician Group Practices/Management
- Post-Acute and Long-Term Care Providers
- Technology